Skip to main content
Fig. 2 | Cancer Cell International

Fig. 2

From: Dynamic changes in peripheral blood lymphocyte subset counts and functions in patients with diffuse large B cell lymphoma during chemotherapy

Fig. 2

The subsets and phenotypes of lymphocytes in patients with DLBCL according to IPI scores. Patients with DLBCL were stratified into low- to low-mediate-risk (IPI scores 0–2) and mediate-high- to high-risk (IPI scores 3–5) groups. The absolute counts of CD3+ T, CD4+ T, CD8+ T cells and NK cells (A), the percentages of CD28+ cells in CD4+ and CD8+ T cells (B), the percentages of HLA-DR+ cells in CD3+ T and CD8+ T cells (C), the percentages of CD45RO+ and CD45RA+ cells in CD4+ T cells (D) and percentages of Tregs in lymphocytes are shown in different groups (mean ± SD). *p < 0.05, **p < 0.01, ***p < 0.001

Back to article page